Granules announces approval of generic equivalent of Excedrin Migraine tablets by USFDA
Hyderabad, Feb 25: Granules India Limited announced on Wednesday that the US Food & Drug Administration (USFDA) has approved its Abbreviated New Drug Application (ANDA) for Acetaminophen, Aspirin and Caffeine Tablets USP, 250 mg/250 mg/65…